A carregar...
A multiplex platform for the identification of ovarian cancer biomarkers
BACKGROUND: Currently, there are no FDA approved screening tools for detecting early stage ovarian cancer in the general population. Development of a biomarker-based assay for early detection would significantly improve the survival of ovarian cancer patients. METHODS: We used a multiplex approach t...
Na minha lista:
| Publicado no: | Clin Proteomics |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5634875/ https://ncbi.nlm.nih.gov/pubmed/29051715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12014-017-9169-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|